Prevention

A comprehensive mycoplasma infection prevention platform consisting of preventive vaccines, pre-illness medical care, social system optimization, and infectious disease-resistant medical systems

The unique "MID Prism" measurement technology makes it possible to identify mycoplasma in diseases that were not previously associated with mycoplasma infections.

Donating Blood
Vaccine concept.jpg

MID vaccine development

Internationally patented vaccine development technology

The technology to develop "mycoplasma lipid antigen" by chemical synthesis as a vaccine is technology exclusively patented by M Bio Technology.

Details

Expansion to pre-symptomatic medical care

Many diseases are caused by mycoplasma. By knowing the cause, it is possible to propose optimal treatments in the pre-illness state.

The technology to develop "mycoplasma lipid antigen" by chemical synthesis as a vaccine is technology exclusively patented by M Bio Technology.

Details
ME-BYO concept.png